Collegium Pharmaceutical (COLL)
(Delayed Data from NSDQ)
$38.78 USD
+1.40 (3.75%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $38.74 -0.04 (-0.10%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth F Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $1.65 | -7.69% |
Earnings Summary
For their last quarter, Collegium Pharmaceutical (COLL) reported earnings of $1.62 per share, beating the Zacks Consensus Estimate of $1.56 per share. This reflects a positive earnings surprise of 3.85%. Look out for COLL's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of $1.65 per share, reflecting a year-over-year increase of 23.13%.
Earnings History
Price & Consensus
Zacks News for COLL
Collegium Pharmaceutical (COLL) Upgraded to Buy: Here's Why
COLL: What are Zacks experts saying now?
Zacks Private Portfolio Services